LoginSign Up
EpiBone

EpiBone

EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.

EpiBone is a biotechnology company headquartered in New York City, New York that was founded in 2013 by Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig. EpiBone uses biomedical engineering to create individualized bone grafts using a patients own mesenchymal stem cells grown in the companies custom built bioreactor.

Funding

Grant

On June 12, 2014 EpiBone received an undisclosed amount of funding in the form of a grant from the Partnership Fund for New York City and Breakout Labs.

Convertible Note

On October 1, 2016 EpiBone received a convertible note worth $560 thousand from Plum Alley.

Timeline

People

Name
Role
Related Golden topics

Cato Laurencin

Advisor

Cliff Schorer

Advisor

Elma Hawkins

Chairman

Gordana Vunjak-Novakovic

Co-Founder & Chief Scientific Advisor

Hank Kucheman

Advisor

Henry Kravis

Advisor

Nina Tando

Co-Founder & CEO

Sarindr Bhumiratana

Co-Founder & CEO

Sidney Eisig

Co-Founder & Chief Clinical Advisor

Further reading

Title
Author
Link
Type

Why Peter Thiel Invested In New York Biotech Startup EpiBone

Liz Welch

News

Documentaries, videos and podcasts

Title
Date
Link

Nina Tandon CEO and Co Founder EpiBone

May 17, 2018

Nina Tandon: Could tissue engineering mean personalized medicine?

December 6, 2018

Companies

Company
CEO
Location
Products/Services

References